Thomas Mcgauley - Nov 17, 2025 Form 4 Insider Report for TENAX THERAPEUTICS, INC. (TENX)

Role
Interim CFO
Signature
/s/ S. Halle Vakani, as Attorney-in-Fact
Stock symbol
TENX
Transactions as of
Nov 17, 2025
Transactions value $
$58,164
Form type
4
Date filed
11/19/2025, 07:01 PM
Previous filing
Dec 6, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
MCGAULEY THOMAS Interim CFO 101 GLEN LENNOX DRIVE SUITE 300, CHAPEL HILL /s/ S. Halle Vakani, as Attorney-in-Fact 2025-11-19 0001550701

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TENX Common Stock Purchase $14.7K +2K $7.34 2K Nov 17, 2025 Direct F1
transaction TENX Common Stock Purchase $7.35K +1K $7.35 1K Nov 17, 2025 By Child
transaction TENX Common Stock Purchase $36.1K +5K $7.23 5K Nov 17, 2025 By Spouse F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $7.14 to $7.43. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F2 This transaction was executed in multiple trades at prices ranging from $7.17 to $7.30. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.